Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)

NCT00846781 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Denufosol tetrasodium Inhalation Solution

Sponsor

Merck Sharp & Dohme LLC